CAMLINFINE vs NOCIL: Stock Comparison

Camlin Fine Sciences Limited vs NOCIL Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

NOCIL Limited is the larger company by market capitalisation. Camlin Fine Sciences Limited shows a higher ROCE, while NOCIL Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Camlin Fine Sciences Limited and NOCIL Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, CAMLINFINE is more favourable on 3 of 13 scored metrics and NOCIL on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NOCIL is the larger company
₹2,680 Cr vs ₹2,370 Cr
P/E Ratio
NOCIL has a lower P/E
48.56x vs 87.01x
P/B Ratio
NOCIL has a lower P/B
1.52x vs 2.31x
EPS
NOCIL has higher earnings per share
₹3.32 vs ₹-1.55
Dividend Yield
NOCIL has a higher dividend yield
1.12% vs 0%
Revenue Growth (TTM YoY)
NOCIL has faster revenue growth
-2.8% vs -2.9%
EPS Growth (TTM YoY)
CAMLINFINE has faster EPS growth
0% vs -19.2%
Qtr Sales Growth
CAMLINFINE has stronger quarterly sales growth
-1.57% vs -2.75%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCAMLINFINENOCIL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricCAMLINFINENOCIL
Live Price₹124.47₹160.11
Day Change3.2%-1.23%
Volume4.71 L3.33 L
52-Week High₹235₹204.5
52-Week Low₹96.21₹125.31
Distance from 52W High-47.03%-21.71%

Valuation

MetricCAMLINFINENOCIL
Market Cap₹2,370 Cr₹2,680 Cr
P/E Ratio87.01x48.56x
P/B Ratio2.31x1.52x
EPS₹-1.55₹3.32
Book Value₹54.17₹106.4
Dividend Yield0%1.12%

Growth

MetricCAMLINFINENOCIL
Revenue Growth (TTM YoY)-2.9%-2.8%
EPS Growth (TTM YoY)0%-19.2%
Qtr Sales Growth-1.57%-2.75%
Qtr Profit Growth-60.5%-18.2%

Profitability & Leverage

MetricCAMLINFINENOCIL
ROE1.26%2.6%
ROCE4.05%3.93%
Net Margin1.57%4.86%
Operating Margin6.2%7.73%
Debt to Equity0.69x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCAMLINFINENOCIL
Promoter Holding15.25%33.76%
FII Holding0.91% 0.03 pp4.78% 0.23 pp
DII Holding5.42% 2.28 pp7.47% 0.44 pp
Public Holding45.64% 2.32 pp53.98% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Camlin Fine Sciences Limited and NOCIL Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.